Semi-Annual Consolidated Statement Of Cash Flows

SANTEN PHARMACEUTICAL CO.,LTD. - Filing #7254751

Concept 2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
25,137,000,000 JPY
25,803,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.